Xylem Inc
NYSE:XYL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
109.69
145.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Xylem Inc
Wall Street
Price Targets
XYL Price Targets Summary
Xylem Inc
According to Wall Street analysts, the average 1-year price target for
XYL
is 153.96 USD
with a low forecast of 126.25 USD and a high forecast of 180.6 USD.
XYL Last Price Targets
Xylem Inc
The latest public price target was made on Aug 13, 2024 by
Damian Karas
from
UBS
,
who expects
XYL
stock to
rise by 41%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Damian Karas
UBS
|
165
USD
Upside 41% |
4 months ago
Aug 13, 2024
|
Xylem initiated with a Buy at UBS
TheFly
|
Michael Halloran
Robert W. Baird
|
170
USD
Upside 45% |
4 months ago
Jul 31, 2024
|
Xylem price target raised to $170 from $155 at Baird
TheFly
|
Bryan Blair
Oppenheimer
|
152
USD
Upside 30% |
6 months ago
May 31, 2024
|
Xylem (XYL) PT Raised to $152 at Oppenheimer
StreetInsider
|
John Eade
Argus Research
|
165
USD
Upside 41% |
6 months ago
May 29, 2024
|
Xylem (XYL) PT Raised to $165 at Argus
StreetInsider
|
Brett Linzey
Mizuho Securities
|
135
USD
Upside 15% |
7 months ago
May 3, 2024
|
Xylem price target raised to $135 from $110 at Mizuho
TheFly
|
|
Michael Halloran
Robert W. Baird
|
155
USD
Upside 32% |
7 months ago
May 3, 2024
|
Xylem price target raised to $155 from $151 at Baird
TheFly
|
Deane Dray
RBC Capital
|
162
USD
Upside 38% |
7 months ago
May 3, 2024
|
Xylem (XYL) PT Raised to $162 at RBC Capital
StreetInsider
|
Brad Hewitt
Wolfe Research
|
143
USD
Upside 22% |
8 months ago
Apr 8, 2024
|
Xylem price target raised to $143 from $138 at Wolfe Research
TheFly
|
|
Deane Dray
RBC Capital
|
153
USD
Upside 31% |
8 months ago
Apr 4, 2024
|
Xylem price target raised to $153 from $145 at RBC Capital
TheFly
|
Nathan Jones
Stifel Nicolaus
|
133
USD
Upside 14% |
1 year ago
Aug 18, 2023
|
Xylem And Evoqua Merger: The Blueprint For Leading Global Smart Water Infrastructure, Predicts Analyst
Benzinga
|
Unknown Analyst
Citigroup
|
121
USD
Upside 3% |
1 year ago
Feb 8, 2023
|
Citigroup Maintains Neutral on Xylem, Lowers Price Target to $121
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is XYL's stock price target?
Price Target
153.96
USD
According to Wall Street analysts, the average 1-year price target for
XYL
is 153.96 USD
with a low forecast of 126.25 USD and a high forecast of 180.6 USD.
What is Xylem Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Xylem Inc's revenue is
9%.
The projected
CAGR
for the next 4 years is
8%.
What is Xylem Inc's Operating Income forecast?
Projected CAGR
24%
For the last 8 years the
compound annual growth rate for
Xylem Inc's operating income is
7%.
The projected
CAGR
for the next 4 years is
24%.
What is Xylem Inc's Net Income forecast?
Projected CAGR
24%
For the last 8 years the
compound annual growth rate for
Xylem Inc's net income is
8%.
The projected
CAGR
for the next 4 years is
24%.
You don't have any saved screeners yet
